FASN and neoplasm: To confirm our results that FASN inhibition preferentially suppresses the growth of mutp53 tumors in xenograft tumor models and mutp53 knock-in mice, different human colorectal cancer organoids expressing mutp53 or wtp53 were used to evaluate the effect of TVB-3166.